Sarepta Therapeutics (SRPT) Assets (2010 - 2026)

Sarepta Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $3.2 billion for Q1 2026.

• In Q1 2026, Assets fell 8.27% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $3.2 billion (down 8.27% YoY), while the FY2025 annual figure was $3.3 billion, down 15.48% from the prior year.
• Assets for Q1 2026 stood at $3.2 billion, down from $3.3 billion in the prior quarter.
• The five-year high for Assets was $4.0 billion in Q4 2024, with the low at $3.0 billion in Q2 2022.
• The 5-year median for Assets is $3.2 billion (2024), against an average of $3.3 billion.
• The sharpest annual moves came in 2024 and 2025: Assets advanced 21.4% in 2024, then decreased 15.48% in 2025.
• Sarepta Therapeutics' Assets stood at $3.1 billion in 2022, then climbed by 4.35% to $3.3 billion in 2023, then advanced by 21.4% to $4.0 billion in 2024, then fell by 15.48% to $3.3 billion in 2025, then slipped by 5.1% to $3.2 billion in 2026.
• Business Quant data shows SRPT's Assets at $3.2 billion in Q1 2026, $3.3 billion in Q4 2025, and $3.5 billion in Q3 2025.